Other
Tramazoline hydrochloride [USAN:JAN]
Safety score · 0–100
Avoid
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
Tramazoline hydrochloride [USAN:JAN] is a cosmetic ingredient used in product formulations. Its specific function may vary between products. Exercise caution due to limited available safety data.
Tramazoline hydrochloride is a pharmaceutical alpha-adrenergic agonist (vasoconstrictor) used primarily in nasal decongestant formulations. It is classified as H301 (toxic if swallowed), H314 (causes severe skin burns and eye damage), H318 (causes serious eye damage), and H411 (toxic to aquatic life with long-lasting effects). This ingredient is a drug substance, not a cosmetic ingredient, and is banned from cosmetic use in the EU.
Known concerns
- Acute toxicity (H301)
- Severe skin/eye damage (H314)
- Serious eye damage (H318)
- Environmental hazard (H411)
- Drug substance not permitted in cosmetics
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find Tramazoline hydrochloride [USAN:JAN] in your products.
Scan any cosmetic product with LuxSense to see if it contains Tramazoline hydrochloride [USAN:JAN] and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.